Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

<p><strong>BRIC markets are outperforming broad EM. </strong>The BRIC/EM ratio is rounding to two year highs. All four member countries are attractive for separate reasons.  This week's “EM Leaders” highlights several attractive themes including: tech stocks, especially semis, construction/farm machinery names and  a selection of consumer stocks across the BRICs markets.</p>

BRIC markets are outperforming broad EM. The BRIC/EM ratio is rounding to two year highs. All four member countries are attractive for separate reasons.  This week's “EM Leaders” highlights several attractive themes including: tech stocks, especially semis, construction/farm machinery names and  a selection of consumer stocks across the BRICs markets.

Brazil

Hypermarcas SA is a Brazilian pharmaceutical company with a presence in the Consumer Health and Primary Care markets. Its products include cough-and-cold medicine, analgesics, antacids, vitamins and dermo-cosmetics. Hypermarcas has its own manufacturing facilities and nationwide distribution, in addition to an innovation center.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hypermarcas SA (HYPE3 BZ)

BRIC Markets Lead EM Higher

BRIC markets are outperforming broad EM. The BRIC/EM ratio is rounding to two year highs. All four member countries are attractive for separate...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)